Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Rural HPV vaccine push aims to prevent cancer in kids

NCT ID NCT07217145

Prevention Sponsor: University of Utah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a clinic-based outreach program can help more rural parents get their children (ages 9-17) the HPV vaccine. Researchers are working with 1,455 families at community clinics in the Mountain West. The goal is to see if simple communication and engagement strategies during routine visits can boost vaccination rates and reduce future cancer disparities.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral outreach intervention
What this could lead to
If successful, this approach could increase HPV vaccination rates in rural communities, helping prevent HPV-related cancers.
What could go wrong
This is a behavioral study, not a medical treatment, so results depend on how well clinics adopt the outreach. It may not work in all settings or for all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

1,455 people

The number who actually took part.

Started

Oct 2025

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination); * P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and * P/C who speak either English or Spanish. Exclusion Criteria: * P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due); * P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy); * P/C of C/A with other factors that would influence CDC HPV recommendations; and * P/C that does not speak Spanish or English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV vaccination are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior Communication neoplasm Patient Acceptance of Health Care human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV vaccination Series completion Uptake vaccination

Contacts and locations

Locations

  • Sea Mar Community Health Centers

    Seattle, Washington, 98108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.